Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma
Single-Arm, Dose-Finding Pilot Trial of Single-Agent Bortezomib in Patients With Relapsed/Refractory AIDS-Associated Kaposi Sarcoma With Correlative Assessments of KSHV and HIV
Status: Enrolling
Updated:  2/19/2018
Memorial Sloan Kettering-Rockefeller Outpatient Pavilion
mi
from
New York, NY
Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma
Single-Arm, Dose-Finding Pilot Trial of Single-Agent Bortezomib in Patients With Relapsed/Refractory AIDS-Associated Kaposi Sarcoma With Correlative Assessments of KSHV and HIV
Status: Enrolling
Updated: 2/19/2018
Memorial Sloan Kettering-Rockefeller Outpatient Pavilion
mi
from
New York, NY
Click here to add this to my saved trials
Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma
Single-Arm, Dose-Finding Pilot Trial of Single-Agent Bortezomib in Patients With Relapsed/Refractory AIDS-Associated Kaposi Sarcoma With Correlative Assessments of KSHV and HIV
Status: Enrolling
Updated:  2/19/2018
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma
Single-Arm, Dose-Finding Pilot Trial of Single-Agent Bortezomib in Patients With Relapsed/Refractory AIDS-Associated Kaposi Sarcoma With Correlative Assessments of KSHV and HIV
Status: Enrolling
Updated: 2/19/2018
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma
Single-Arm, Dose-Finding Pilot Trial of Single-Agent Bortezomib in Patients With Relapsed/Refractory AIDS-Associated Kaposi Sarcoma With Correlative Assessments of KSHV and HIV
Status: Enrolling
Updated:  2/19/2018
Virginia Mason Medical Center
mi
from
Seattle, WA
Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma
Single-Arm, Dose-Finding Pilot Trial of Single-Agent Bortezomib in Patients With Relapsed/Refractory AIDS-Associated Kaposi Sarcoma With Correlative Assessments of KSHV and HIV
Status: Enrolling
Updated: 2/19/2018
Virginia Mason Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Social Contextual Influences on Physical Activity
Social, Contextual, and Environmental Determinants of Physical Activity in Sedentary Minority Adults
Status: Enrolling
Updated:  2/19/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Social Contextual Influences on Physical Activity
Social, Contextual, and Environmental Determinants of Physical Activity in Sedentary Minority Adults
Status: Enrolling
Updated: 2/19/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Study in Japan and Ex-Japan to Characterize the Pharmacokinetic and Pharmacodynamic Response to Orteronel (TAK-700) in Chemotherapy-Naive Participants With Castration-Resistant Prostate Cancer
A Study in Japan and Ex-Japan to Characterize the Pharmacokinetic and Pharmacodynamic Response to Orteronel (TAK-700) in Chemotherapy-Naive Patients With Castration-Resistant Prostate Cancer
Status: Enrolling
Updated:  2/19/2018
Urology Cancer Center, PC
mi
from
Omaha, NE
Study in Japan and Ex-Japan to Characterize the Pharmacokinetic and Pharmacodynamic Response to Orteronel (TAK-700) in Chemotherapy-Naive Participants With Castration-Resistant Prostate Cancer
A Study in Japan and Ex-Japan to Characterize the Pharmacokinetic and Pharmacodynamic Response to Orteronel (TAK-700) in Chemotherapy-Naive Patients With Castration-Resistant Prostate Cancer
Status: Enrolling
Updated: 2/19/2018
Urology Cancer Center, PC
mi
from
Omaha, NE
Click here to add this to my saved trials
Smart Phone Application in Increasing Physical Activity in Breast Cancer Survivors
Facilitating Motivational Readiness and Adoption of Physical Activity by Breast Cancer Survivors With a Smart Phone Application
Status: Enrolling
Updated:  2/19/2018
Sidney Kimmel Cancer Center - Thomas Jefferson University
mi
from
Philadelphia, PA
Smart Phone Application in Increasing Physical Activity in Breast Cancer Survivors
Facilitating Motivational Readiness and Adoption of Physical Activity by Breast Cancer Survivors With a Smart Phone Application
Status: Enrolling
Updated: 2/19/2018
Sidney Kimmel Cancer Center - Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian Cancer
Multicenter Trial on Utility and Impact of Computed Tomography and Serum CA-125 in Management of Newly Diagnosed Ovarian Cancer
Status: Enrolling
Updated:  2/20/2018
Johns Hopkins Hospital
mi
from
Baltimore, MD
A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian Cancer
Multicenter Trial on Utility and Impact of Computed Tomography and Serum CA-125 in Management of Newly Diagnosed Ovarian Cancer
Status: Enrolling
Updated: 2/20/2018
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian Cancer
Multicenter Trial on Utility and Impact of Computed Tomography and Serum CA-125 in Management of Newly Diagnosed Ovarian Cancer
Status: Enrolling
Updated:  2/20/2018
Memoral Sloan Kettering Cancer Center
mi
from
Basking Ridge, NJ
A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian Cancer
Multicenter Trial on Utility and Impact of Computed Tomography and Serum CA-125 in Management of Newly Diagnosed Ovarian Cancer
Status: Enrolling
Updated: 2/20/2018
Memoral Sloan Kettering Cancer Center
mi
from
Basking Ridge, NJ
Click here to add this to my saved trials
A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian Cancer
Multicenter Trial on Utility and Impact of Computed Tomography and Serum CA-125 in Management of Newly Diagnosed Ovarian Cancer
Status: Enrolling
Updated:  2/20/2018
Memorial Sloan-Kettering Cancer Center @ Suffolk
mi
from
Commack, NY
A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian Cancer
Multicenter Trial on Utility and Impact of Computed Tomography and Serum CA-125 in Management of Newly Diagnosed Ovarian Cancer
Status: Enrolling
Updated: 2/20/2018
Memorial Sloan-Kettering Cancer Center @ Suffolk
mi
from
Commack, NY
Click here to add this to my saved trials
A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian Cancer
Multicenter Trial on Utility and Impact of Computed Tomography and Serum CA-125 in Management of Newly Diagnosed Ovarian Cancer
Status: Enrolling
Updated:  2/20/2018
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian Cancer
Multicenter Trial on Utility and Impact of Computed Tomography and Serum CA-125 in Management of Newly Diagnosed Ovarian Cancer
Status: Enrolling
Updated: 2/20/2018
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian Cancer
Multicenter Trial on Utility and Impact of Computed Tomography and Serum CA-125 in Management of Newly Diagnosed Ovarian Cancer
Status: Enrolling
Updated:  2/20/2018
M.D. Anderson Cancer Center
mi
from
Houston, TX
A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian Cancer
Multicenter Trial on Utility and Impact of Computed Tomography and Serum CA-125 in Management of Newly Diagnosed Ovarian Cancer
Status: Enrolling
Updated: 2/20/2018
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Sexual Behavior in Head and Neck Cancer Patients
Sexual Behavior in Head and Neck Cancer Patients
Status: Enrolling
Updated:  2/20/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Sexual Behavior in Head and Neck Cancer Patients
Sexual Behavior in Head and Neck Cancer Patients
Status: Enrolling
Updated: 2/20/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Longitudinal Study of Symptoms in Colorectal Cancer
Prospective Study of Symptoms Related to Oxaliplatin-based Regimens in the Treatment of Colorectal Cancer
Status: Enrolling
Updated:  2/20/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Longitudinal Study of Symptoms in Colorectal Cancer
Prospective Study of Symptoms Related to Oxaliplatin-based Regimens in the Treatment of Colorectal Cancer
Status: Enrolling
Updated: 2/20/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Neo-adjuvant Chemoradiation With Oxaliplatin/5-FU in Rectal Cancer
A Phase II Open-labeled, Prospective Study to Determine the Efficacy of Preoperative Chemoradiation With Oxaliplatin/5-FU in Locally Advanced Rectal Cancer Followed by Total Mesorectal Excision and FOLFOX6
Status: Enrolling
Updated:  2/20/2018
Beth Israel Medical Center - Philipps Ambulatory Care Center
mi
from
New York, NY
Neo-adjuvant Chemoradiation With Oxaliplatin/5-FU in Rectal Cancer
A Phase II Open-labeled, Prospective Study to Determine the Efficacy of Preoperative Chemoradiation With Oxaliplatin/5-FU in Locally Advanced Rectal Cancer Followed by Total Mesorectal Excision and FOLFOX6
Status: Enrolling
Updated: 2/20/2018
Beth Israel Medical Center - Philipps Ambulatory Care Center
mi
from
New York, NY
Click here to add this to my saved trials
Neo-adjuvant Chemoradiation With Oxaliplatin/5-FU in Rectal Cancer
A Phase II Open-labeled, Prospective Study to Determine the Efficacy of Preoperative Chemoradiation With Oxaliplatin/5-FU in Locally Advanced Rectal Cancer Followed by Total Mesorectal Excision and FOLFOX6
Status: Enrolling
Updated:  2/20/2018
St. Luke's-Roosevelt Hospital Center - Roosevelt Division
mi
from
New York, NY
Neo-adjuvant Chemoradiation With Oxaliplatin/5-FU in Rectal Cancer
A Phase II Open-labeled, Prospective Study to Determine the Efficacy of Preoperative Chemoradiation With Oxaliplatin/5-FU in Locally Advanced Rectal Cancer Followed by Total Mesorectal Excision and FOLFOX6
Status: Enrolling
Updated: 2/20/2018
St. Luke's-Roosevelt Hospital Center - Roosevelt Division
mi
from
New York, NY
Click here to add this to my saved trials
Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer
A Phase II Study of Letrozole and RAD001 (Everolimus) in Patients With Advanced or Recurrent Endometrial Cancer
Status: Enrolling
Updated:  2/20/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer
A Phase II Study of Letrozole and RAD001 (Everolimus) in Patients With Advanced or Recurrent Endometrial Cancer
Status: Enrolling
Updated: 2/20/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer
A Phase II Study of Letrozole and RAD001 (Everolimus) in Patients With Advanced or Recurrent Endometrial Cancer
Status: Enrolling
Updated:  2/20/2018
Morristown Memorial Hospital, Women's Cancer Center
mi
from
Morristown, NJ
Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer
A Phase II Study of Letrozole and RAD001 (Everolimus) in Patients With Advanced or Recurrent Endometrial Cancer
Status: Enrolling
Updated: 2/20/2018
Morristown Memorial Hospital, Women's Cancer Center
mi
from
Morristown, NJ
Click here to add this to my saved trials
Symptom Inventory for Gastrointestinal Stromal Tumors
Symptom Burden in Patients With Gastrointestinal Stromal Tumors (GISTs)
Status: Enrolling
Updated:  2/20/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Symptom Inventory for Gastrointestinal Stromal Tumors
Symptom Burden in Patients With Gastrointestinal Stromal Tumors (GISTs)
Status: Enrolling
Updated: 2/20/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Stereotactic Body Radiotherapy for Unresectable Pancreatic Cancer
Phase IV Trial Evaluating the Use of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Unresectable Pancreatic Cancer
Status: Enrolling
Updated:  2/20/2018
St John's Mercy Medical Center
mi
from
Saint Louis, MO
Stereotactic Body Radiotherapy for Unresectable Pancreatic Cancer
Phase IV Trial Evaluating the Use of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Unresectable Pancreatic Cancer
Status: Enrolling
Updated: 2/20/2018
St John's Mercy Medical Center
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Phase 2 Trial of AEZS-108 in Chemotherapy Refractory in Triple Negative Breast Cancer
A Randomized Phase 2 Trial of AEZS-108 in Chemotherapy Refractory Triple Negative, LHRH-positive Metastatic Breast Cancer.
Status: Enrolling
Updated:  2/20/2018
University of Miami
mi
from
Miami, FL
Phase 2 Trial of AEZS-108 in Chemotherapy Refractory in Triple Negative Breast Cancer
A Randomized Phase 2 Trial of AEZS-108 in Chemotherapy Refractory Triple Negative, LHRH-positive Metastatic Breast Cancer.
Status: Enrolling
Updated: 2/20/2018
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Phase 2 Trial of AEZS-108 in Chemotherapy Refractory in Triple Negative Breast Cancer
A Randomized Phase 2 Trial of AEZS-108 in Chemotherapy Refractory Triple Negative, LHRH-positive Metastatic Breast Cancer.
Status: Enrolling
Updated:  2/20/2018
Universitäts-Frauenklinik
mi
from
Göttingen,
Phase 2 Trial of AEZS-108 in Chemotherapy Refractory in Triple Negative Breast Cancer
A Randomized Phase 2 Trial of AEZS-108 in Chemotherapy Refractory Triple Negative, LHRH-positive Metastatic Breast Cancer.
Status: Enrolling
Updated: 2/20/2018
Universitäts-Frauenklinik
mi
from
Göttingen,
Click here to add this to my saved trials
Gadoxetate Enhanced Imaging Study to Detect Prostate Cancer
Pilot Study of Eovist (Gadoxetate) Enhanced MRI for the Detection of Prostate Cancer
Status: Enrolling
Updated:  2/20/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Gadoxetate Enhanced Imaging Study to Detect Prostate Cancer
Pilot Study of Eovist (Gadoxetate) Enhanced MRI for the Detection of Prostate Cancer
Status: Enrolling
Updated: 2/20/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors
A Pilot Study of the Clinical Implementation of the Carevive Survivor Care Planning System
Status: Enrolling
Updated:  2/20/2018
Sidney Kimmel Cancer Center - Thomas Jefferson University
mi
from
Philadelphia, PA
Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors
A Pilot Study of the Clinical Implementation of the Carevive Survivor Care Planning System
Status: Enrolling
Updated: 2/20/2018
Sidney Kimmel Cancer Center - Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors
A Pilot Study of the Clinical Implementation of the Carevive Survivor Care Planning System
Status: Enrolling
Updated:  2/20/2018
Reading Hospital
mi
from
Reading, PA
Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors
A Pilot Study of the Clinical Implementation of the Carevive Survivor Care Planning System
Status: Enrolling
Updated: 2/20/2018
Reading Hospital
mi
from
Reading, PA
Click here to add this to my saved trials
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  2/20/2018
AOI Pharmaceuticals Investigative Site
mi
from
Tucson, AZ
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 2/20/2018
AOI Pharmaceuticals Investigative Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  2/20/2018
AOI Pharmaceuticals Investigative Site
mi
from
Pomona, CA
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 2/20/2018
AOI Pharmaceuticals Investigative Site
mi
from
Pomona, CA
Click here to add this to my saved trials
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  2/20/2018
AOI Pharmaceuticals Investigative Site
mi
from
Aventura, FL
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 2/20/2018
AOI Pharmaceuticals Investigative Site
mi
from
Aventura, FL
Click here to add this to my saved trials
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  2/20/2018
AOI Pharmaceuticals Investigative Site
mi
from
Hollywood, FL
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 2/20/2018
AOI Pharmaceuticals Investigative Site
mi
from
Hollywood, FL
Click here to add this to my saved trials
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  2/20/2018
AOI Pharmaceuticals Investigative Site
mi
from
Lakeland, FL
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 2/20/2018
AOI Pharmaceuticals Investigative Site
mi
from
Lakeland, FL
Click here to add this to my saved trials
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  2/20/2018
AOI Pharmaceuticals Investigative Site
mi
from
Ormond Beach, FL
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 2/20/2018
AOI Pharmaceuticals Investigative Site
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  2/20/2018
AOI Pharmaceuticals Investigative Site
mi
from
Lawrenceville, GA
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 2/20/2018
AOI Pharmaceuticals Investigative Site
mi
from
Lawrenceville, GA
Click here to add this to my saved trials
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  2/20/2018
AOI Pharmaceuticals Investigative Site
mi
from
Galesburg, IL
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 2/20/2018
AOI Pharmaceuticals Investigative Site
mi
from
Galesburg, IL
Click here to add this to my saved trials
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  2/20/2018
AOI Pharmaceuticals Investigative Site
mi
from
New Albany, IN
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 2/20/2018
AOI Pharmaceuticals Investigative Site
mi
from
New Albany, IN
Click here to add this to my saved trials
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  2/20/2018
AOI Pharmaceuticals Investigative Site
mi
from
Grand Rapids, MI
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 2/20/2018
AOI Pharmaceuticals Investigative Site
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  2/20/2018
AOI Pharmaceuticals Investigative Site
mi
from
Kalamazoo, MI
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 2/20/2018
AOI Pharmaceuticals Investigative Site
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  2/20/2018
AOI Pharmaceuticals Investigative Site
mi
from
Billings, MT
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 2/20/2018
AOI Pharmaceuticals Investigative Site
mi
from
Billings, MT
Click here to add this to my saved trials
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  2/20/2018
AOI Pharmaceuticals Investigative Site
mi
from
Albuquerque, NM
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 2/20/2018
AOI Pharmaceuticals Investigative Site
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  2/20/2018
AOI Pharmaceuticals Investigative Site
mi
from
Albany, NY
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 2/20/2018
AOI Pharmaceuticals Investigative Site
mi
from
Albany, NY
Click here to add this to my saved trials
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  2/20/2018
AOI Pharmaceuticals Investigative Site
mi
from
Armonk, NY
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 2/20/2018
AOI Pharmaceuticals Investigative Site
mi
from
Armonk, NY
Click here to add this to my saved trials
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  2/20/2018
AOI Pharmaceuticals Investigative Site
mi
from
Greenville, SC
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 2/20/2018
AOI Pharmaceuticals Investigative Site
mi
from
Greenville, SC
Click here to add this to my saved trials
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  2/20/2018
AOI Pharmaceuticals Investigative Site
mi
from
Chattanooga, TN
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 2/20/2018
AOI Pharmaceuticals Investigative Site
mi
from
Chattanooga, TN
Click here to add this to my saved trials
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  2/20/2018
AOI Pharmaceuticals Investigative Site
mi
from
Nashville, TN
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 2/20/2018
AOI Pharmaceuticals Investigative Site
mi
from
Nashville, TN
Click here to add this to my saved trials
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  2/20/2018
AOI Pharmaceuticals Investigative Site
mi
from
Dallas, TX
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 2/20/2018
AOI Pharmaceuticals Investigative Site
mi
from
Dallas, TX
Click here to add this to my saved trials
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  2/20/2018
AOI Pharmaceuticals Investigative Site
mi
from
Tyler, TX
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 2/20/2018
AOI Pharmaceuticals Investigative Site
mi
from
Tyler, TX
Click here to add this to my saved trials
Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Previously Hormone Responsive Metastatic Breast Ca.
The Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Metastatic Breast Cancer Patients Previously Responsive to Hormonal Therapy: A Phase II Trial
Status: Enrolling
Updated:  2/20/2018
University of Alabama at Birmingham
mi
from
Birmingham, AL
Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Previously Hormone Responsive Metastatic Breast Ca.
The Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Metastatic Breast Cancer Patients Previously Responsive to Hormonal Therapy: A Phase II Trial
Status: Enrolling
Updated: 2/20/2018
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Safety and Efficacy of Belinostat When Used With Standard of Care Chemotherapy for Untreated Non-small Cell Lung Cancer
Phase Ib/II Study to Determine the Recommended Dose, Safety, and Preliminary Efficacy of Belinostat When Used in Combination With Carboplatin, Paclitaxel, and Bevacizumab in Patients With Untreated Non-small Cell Lung Cancer.
Status: Enrolling
Updated:  2/21/2018
Holy Cross Hospital
mi
from
Fort Lauderdale, FL
Safety and Efficacy of Belinostat When Used With Standard of Care Chemotherapy for Untreated Non-small Cell Lung Cancer
Phase Ib/II Study to Determine the Recommended Dose, Safety, and Preliminary Efficacy of Belinostat When Used in Combination With Carboplatin, Paclitaxel, and Bevacizumab in Patients With Untreated Non-small Cell Lung Cancer.
Status: Enrolling
Updated: 2/21/2018
Holy Cross Hospital
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Evaluation of Low-dose Irinotecan and Cyberknife® SBRT to Treat Colorectal Cancer With Limited Liver Metastasis
Prospective Evaluation of Low-dose Irinotecan and Cyberknife® Stereotactic Body Radiotherapy in the Treatment of Patients With Colorectal Cancer and Limited Liver Metastasis
Status: Enrolling
Updated:  2/21/2018
Advocate Lutheran General Hospital
mi
from
Park Ridge, IL
Evaluation of Low-dose Irinotecan and Cyberknife® SBRT to Treat Colorectal Cancer With Limited Liver Metastasis
Prospective Evaluation of Low-dose Irinotecan and Cyberknife® Stereotactic Body Radiotherapy in the Treatment of Patients With Colorectal Cancer and Limited Liver Metastasis
Status: Enrolling
Updated: 2/21/2018
Advocate Lutheran General Hospital
mi
from
Park Ridge, IL
Click here to add this to my saved trials
Pilot Project for Cardiopulmonary and Functional Evaluation in Patients With Pancreatic Cancer Associated Cachexia
Pilot Project for Cardiopulmonary and Functional Evaluation in Patients With Pancreatic Cancer Associated Cachexia
Status: Enrolling
Updated:  2/21/2018
Indiana University Melvin and Bren Simon Cancer Center
mi
from
Indianapolis, IN
Pilot Project for Cardiopulmonary and Functional Evaluation in Patients With Pancreatic Cancer Associated Cachexia
Pilot Project for Cardiopulmonary and Functional Evaluation in Patients With Pancreatic Cancer Associated Cachexia
Status: Enrolling
Updated: 2/21/2018
Indiana University Melvin and Bren Simon Cancer Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Pilot Project for Cardiopulmonary and Functional Evaluation in Patients With Pancreatic Cancer Associated Cachexia
Pilot Project for Cardiopulmonary and Functional Evaluation in Patients With Pancreatic Cancer Associated Cachexia
Status: Enrolling
Updated:  2/21/2018
Sidney and Lois Eskenazi Hospital
mi
from
Indianapolis, IN
Pilot Project for Cardiopulmonary and Functional Evaluation in Patients With Pancreatic Cancer Associated Cachexia
Pilot Project for Cardiopulmonary and Functional Evaluation in Patients With Pancreatic Cancer Associated Cachexia
Status: Enrolling
Updated: 2/21/2018
Sidney and Lois Eskenazi Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated:  2/21/2018
Mayo Clinic Scottsdale
mi
from
Scottsdale, AZ
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
A Phase II Trial of Chemoradiotherapy and Local Excision for uT2uN0 Rectal Cancer
Status: Enrolling
Updated: 2/21/2018
Mayo Clinic Scottsdale
mi
from
Scottsdale, AZ
Click here to add this to my saved trials